Women and epilepsy;Kvinner og epilepsi

Tidsskrift for den Norske Laegeforening

Volumn 123, Issue 12, 2003, Pages 1691-1694

  Taubøll, Erik ^a   Gjerstad, Leif ^a   Henriksen, Tore ^a   Husby, Henrik ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; BENZODIAZEPINE DERIVATIVE; CLOBAZAM; CLOMIFENE; GOSERELIN; ORAL CONTRACEPTIVE AGENT;

CHILDBIRTH; DRUG ANTAGONISM; EPILEPSY; FEMALE; HAIR LOSS; HUMAN; MENOPAUSE; MENSTRUAL CYCLE; MENSTRUATION DISORDER; OSTEOPOROSIS; OVARY POLYCYSTIC DISEASE; PATIENT COMPLIANCE; PREGNANCY; REVIEW; SEIZURE; SEX DIFFERENCE; SEXUAL DYSFUNCTION; SIDE EFFECT; SKIN DISEASE; WEIGHT GAIN; MENSTRUATION; PATHOPHYSIOLOGY; PREGNANCY COMPLICATION; SEXUALITY; WOMEN'S HEALTH;

ANTICONVULSANTS; EPILEPSY; FEMALE; HUMANS; MENOPAUSE; MENSTRUATION; PREGNANCY; PREGNANCY COMPLICATIONS; SEX FACTORS; SEXUALITY; WOMEN'S HEALTH;

EID: 0142122194     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. Morrell MJ. Epilepsy in women: the science of why it is special. Neurology 1999; 53 (suppl 1): 42-8.
2. Betts T. Managing epilepsy in young women. Curr Obstet Gynaecol 2000; 10: 202-7.
3. Morrell MJ. Effects of epilepsy on women's reproductive health. Epilepsia 1998; 39 (suppl 8): 32-37.
4. Klein P, Herzog AG. Hormonal effects on epilepsy in women. Epilepsia 1998; 39 (suppl 8): 9-16.
5. Pritchard PB III. Hormone changes in epilepsy. I: Engel J, Pedley T red. Epilepsy: a comprehensive textbook. Philadelphia: Lippincott-Raven, 1997: 1997-2002.
6. Isojärvi JIT, Laatikainen TJ, Pakarinen AJ, Juntunen KTS, Myllylä VV. Polycystic ovaries and hyperandrogenism in women taking valproate for epilepsy. N Engl J Med 1993; 329: 1383-8.
7. Isojärvi JIT, Taubøll E, Pakarinen AJ, Van Parys J, Rättyä J, Harbo HF et al. Altered ovarian function and cardiovascular risks in valproate treated women. Am J Med 2001; 111: 290-6.
8. Røste LS, Taubøll E, Berner A, Isojärvi JIT, Gjerstad L. Valproate, but not lamotrigine, induced ovarian morphological changes in Wistar rats. Exp Toxicol Pathol 2001; 52; 545-52.
9. Røste LS, Taubøll E, Isojärvi JIT, Pakarinen AJ, Huhtaniemi I, Gjerstad L. Effects of chronic valproate treatment on reproductive endocrine function in female and male Wistar rats. Reprod Toxicol 2002; 16: 767-73.
10. Taubøll E, Gregoraszczuk EL, Kolodziej A, Kajta M, Ropstad E. Valproate inhibits the conversion of testosterone to estradiol and acts as an apoptotic agent in growing porcine ovarian follicular cells. Epilepsia, akseptert for publisering, 2003.
11. Yerby MS. Special considerations for women with epilepsy. Pharmacotherapy 2000; 20 (8 Pt 2): 159-70.
12. Herzog AG, Klein P, Ransil BJ. Three patterns of catamenial epilepsy. Epilepsia 1997; 38: 1082-8.
13. Majewska MD, Harrison NL, Schwartz RD, Barker JL, Paul SM. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science 1986; 232: 1004-7.
14. Taubøll E, Lindström S. The effect of progesterone and its metabolite 5α-pregnan-3α-ol-20-one on focal epileptic seizures in the cat's visual cortex in vivo. Epilepsy Res 1993; 14: 17-30.
15. Betts T, Crawford P. Women and epilepsy. London: Martin Dunitz, 1998, 1-84.
16. Guberman A. Hormonal contraception and epilepsy. Neurology 1999; 53 (suppl 1): 38-40.
17. Lambert MV. Seizures, hormones and sexuality. Seizure 2001; 10: 319-40.
18. Morrell MJ. Sexuality in epilepsy. I: Engel J, Pedley T, red. A Comprehensive textbook of epilepsy. Philadelphia: Lippincott-Raven, 1997: 2021-6.
19. Morrell MJ. Managing epilepsy in women across the reproductive cycle. A CME monograph for neurologists. Secaucus, NJ: Projects in knowledge, 2001: 1-30.
20. Pack AM, Morrell MJ. Adverse effects of antiepileptic drugs on bone structure: epidemiology, mechanisms and therapeutic implications. CNS Drugs 2001; 15: 633-42.